Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1983 2
1984 1
1985 1
1986 2
1987 1
1988 4
1989 6
1990 4
1991 4
1992 2
1993 4
1994 4
1995 3
1996 4
1997 3
1998 7
1999 5
2000 2
2001 5
2002 1
2003 3
2004 2
2005 1
2006 2
2007 4
2008 5
2009 1
2010 1
2011 4
2012 4
2013 4
2014 2
2015 9
2016 3
2017 6
2018 3
2019 5
2020 3
2021 3
2022 4
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
From International Assistive Technology Professional Organisations.
Layton NA, Smith RO, Cudd P, Lee S, Okigawa E. Layton NA, et al. Disabil Rehabil Assist Technol. 2018 Apr;13(3):323-324. doi: 10.1080/17483107.2017.1379102. Epub 2017 Nov 2. Disabil Rehabil Assist Technol. 2018. PMID: 29094628 No abstract available.
Aggregation of human plasma and of human blood induced in vitro by filgrastim originator product; effect of PEGylation.
Arvinte T, Poirier E, Cudd A, Ersayin N, Darpin G, Dowd J, Brokx S. Arvinte T, et al. Eur J Pharm Biopharm. 2024 Jan;194:148-158. doi: 10.1016/j.ejpb.2023.12.004. Epub 2023 Dec 12. Eur J Pharm Biopharm. 2024. PMID: 38097022 Free article.
We herein report that filgrastim product Neupogen and the filgrastim formulation buffer induced aggregate formation when mixed in vitro with human plasma, and formation of large membranous erythrocyte aggregates when mixed with human blood, similar to the aggregation induced by p …
We herein report that filgrastim product Neupogen and the filgrastim formulation buffer induced aggregate formation when mixed in vitro with …
Chronic liver injury promotes hepatocarcinogenesis of the LEC rat.
Sawaki M, Hattori A, Tsuzuki N, Sugawara N, Enomoto K, Sawada N, Mori M. Sawaki M, et al. Carcinogenesis. 1998 Feb;19(2):331-5. doi: 10.1093/carcin/19.2.331. Carcinogenesis. 1998. PMID: 9498285
We attempted to elucidate the role of prolonged liver cell injury on LEC rat hepatocarcinogenesis using a copper-deficient diet (CuDD) to inhibit the occurrence of consequent liver injury. The animals were fed the CuDD from the age of 4 weeks until being killed at t …
We attempted to elucidate the role of prolonged liver cell injury on LEC rat hepatocarcinogenesis using a copper-deficient diet (CuDD …
User attitudes towards virtual home assessment technologies.
Lanfranchi V, Jones N, Read J, Fegan C, Field B, Simpson E, Revitt C, Cudd P, Ciravegna F. Lanfranchi V, et al. J Med Eng Technol. 2022 Aug;46(6):536-546. doi: 10.1080/03091902.2022.2089250. Epub 2022 Jun 22. J Med Eng Technol. 2022. PMID: 35730495
Search for Electron Antineutrino Appearance in a Long-Baseline Muon Antineutrino Beam.
Abe K, Akutsu R, Ali A, Alt C, Andreopoulos C, Anthony L, Antonova M, Aoki S, Ariga A, Asada Y, Ashida Y, Atkin ET, Awataguchi Y, Ban S, Barbi M, Barker GJ, Barr G, Barrow D, Barry C, Batkiewicz-Kwasniak M, Beloshapkin A, Bench F, Berardi V, Berkman S, Berns L, Bhadra S, Bienstock S, Blondel A, Bolognesi S, Bourguille B, Boyd SB, Brailsford D, Bravar A, Bravo Berguño D, Bronner C, Bubak A, Buizza Avanzini M, Calcutt J, Campbell T, Cao S, Cartwright SL, Catanesi MG, Cervera A, Chappell A, Checchia C, Cherdack D, Chikuma N, Christodoulou G, Coleman J, Collazuol G, Cook L, Coplowe D, Cudd A, Dabrowska A, De Rosa G, Dealtry T, Denner PF, Dennis SR, Densham C, Di Lodovico F, Dokania N, Dolan S, Doyle TA, Drapier O, Dumarchez J, Dunne P, Eklund L, Emery-Schrenk S, Ereditato A, Fernandez P, Feusels T, Finch AJ, Fiorentini GA, Fiorillo G, Francois C, Friend M, Fujii Y, Fujita R, Fukuda D, Fukuda R, Fukuda Y, Fusshoeller K, Gameil K, Giganti C, Golan T, Gonin M, Gorin A, Guigue M, Hadley DR, Haigh JT, Hamacher-Baumann P, Hartz M, Hasegawa T, Hastings NC, Hayashino T, Hayato Y, Hiramoto A, Hogan M, Holeczek J, Hong Van NT, Iacob F, Ichikawa AK, Ikeda M, Ishida T, Ishii T, Ishitsuka M, Iwamo… See abstract for full author list ➔ Abe K, et al. Phys Rev Lett. 2020 Apr 24;124(16):161802. doi: 10.1103/PhysRevLett.124.161802. Phys Rev Lett. 2020. PMID: 32383902 Free article.
Cangrelor for treatment of coronary thrombosis.
Fugate SE, Cudd LA. Fugate SE, et al. Ann Pharmacother. 2006 May;40(5):925-30. doi: 10.1345/aph.1G120. Epub 2006 Apr 4. Ann Pharmacother. 2006. PMID: 16595568 Review.
131 results